Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

Suzhou Highfine Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	495.86	451.87	388.79	447.46	369.43	282.35
Other Revenue	-	-	-	-	0.01	-
Revenue	495.86	451.87	388.79	447.46	369.44	282.35
Revenue Growth (YoY)	39.75%	16.22%	-13.11%	21.12%	30.85%	47.63%
Cost of Revenue	298.69	272.51	243.44	254.68	197.97	150.36
Gross Profit	197.17	179.36	145.36	192.78	171.47	131.99
Selling, General & Admin	46.19	43.13	35.97	25.25	24.48	49.92
Research & Development	35.46	35.99	28.47	22.26	14.8	22.46
Other Operating Expenses	2.14	-2.48	1.71	3.39	3.14	2.44
Operating Expenses	83.69	76.64	66.15	50.9	44.03	74.65
Operating Income	113.48	102.72	79.21	141.88	127.44	57.33
Interest Expense	-0.1	-0.09	-0.05	-0.24	-0.09	-0.04
Interest & Investment Income	37.67	40.68	29.01	1.07	1.96	2.04
Currency Exchange Gain (Loss)	3.33	3.33	-0.01	3.71	-2.33	-5.82
Other Non Operating Income (Expenses)	-2.77	-0.77	-0.18	-0.16	-0.13	-0.11
EBT Excluding Unusual Items	151.61	145.87	107.99	146.26	126.86	53.41
Gain (Loss) on Sale of Investments	6.68	5.64	0.22	-	0	-
Gain (Loss) on Sale of Assets	-0.13	-0.03	-0	-0.12	-0.03	0
Asset Writedown	-1.38	-0.36	-0.08	-0.28	-0.08	-0.1
Other Unusual Items	4	3.52	4.36	3.11	2.3	1.31
Pretax Income	160.78	154.64	112.49	148.96	129.05	54.62
Income Tax Expense	21.75	20.58	13.51	19.59	17.65	14.22
Net Income	139.02	134.05	98.97	129.37	111.4	40.4
Net Income to Common	139.02	134.05	98.97	129.37	111.4	40.4
Net Income Growth	50.27%	35.44%	-23.50%	16.13%	175.73%	-30.49%
Shares Outstanding (Basic)	107	107	92	81	81	81
Shares Outstanding (Diluted)	109	108	92	81	81	81
Shares Change (YoY)	9.79%	16.87%	14.40%	0.16%	-0.10%	0.10%
EPS (Basic)	1.30	1.25	1.07	1.60	1.38	0.50
EPS (Diluted)	1.28	1.24	1.07	1.60	1.38	0.50
EPS Growth	36.87%	15.89%	-33.13%	15.94%	176.00%	-30.56%
Free Cash Flow	-3.89	18.62	-32.64	57.27	22.42	21.74
Free Cash Flow Per Share	-0.04	0.17	-0.35	0.71	0.28	0.27
Dividend Per Share	0.390	0.390	0.250	0.250	2.500	-
Dividend Growth	56.00%	56.00%	-	-90.00%	-	-
Gross Margin	39.76%	39.69%	37.39%	43.08%	46.41%	46.75%
Operating Margin	22.89%	22.73%	20.37%	31.71%	34.50%	20.31%
Profit Margin	28.04%	29.67%	25.46%	28.91%	30.15%	14.31%
Free Cash Flow Margin	-0.78%	4.12%	-8.40%	12.80%	6.07%	7.70%
EBITDA	133.08	120.99	92.14	152.28	133.62	59.34
EBITDA Margin	26.84%	26.78%	23.70%	34.03%	36.17%	21.02%
D&A For EBITDA	19.6	18.27	12.94	10.41	6.18	2.01
EBIT	113.48	102.72	79.21	141.88	127.44	57.33
EBIT Margin	22.89%	22.73%	20.37%	31.71%	34.50%	20.31%
Effective Tax Rate	13.53%	13.31%	12.01%	13.15%	13.68%	26.03%
Revenue as Reported	495.86	451.87	388.79	447.46	369.44	282.35
Advertising Expenses	-	2.36	2.03	0.47	0.64	0.4

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.